Table 2.
Treatment-related information
| Characteristic | N | % |
|---|---|---|
| Stagea | ||
| 0 | 5 | 13.5 |
| I | 9 | 24.3 |
| II | 17 | 45.9 |
| III | 5 | 13.5 |
| Radiationb | 18 | 48.6 |
| Endocrine therapyb | 21 | 56.8 |
| Herceptinb | 6 | 16.2 |
| Chemotherapyc | 19 | 51.4 |
Note. N = 37 unless otherwise noted. Reported numbers and percentages reflect those who indicated they underwent radiation, endocrine therapy or chemotherapy, or took Herceptin, during the course of their breast cancer treatment.
aData missing/unknown for one participant.
bData missing/unknown for six participants.
cData missing/unknown for seven participants.